HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats.

Abstract
Zingiber officinale (ZO), commonly known as ginger, has been traditionally used in the treatment of diabetes mellitus. Several studies have reported the hypoglycaemic properties of ginger in animal models. The present study evaluated the antihyperglycaemic effect of its aqueous extract administered orally (daily) in three different doses (100, 300, 500 mg/kg body weight) for a period of 30 d to streptozotocin (STZ)-induced diabetic rats. A dose-dependent antihyperglycaemic effect revealed a decrease of plasma glucose levels by 38 and 68 % on the 15th and 30th day, respectively, after the rats were given 500 mg/kg. The 500 mg/kg ZO significantly (P<0·05) decreased kidney weight (% body weight) in ZO-treated diabetic rats v. control rats, although the decrease in liver weight (% body weight) was not statistically significant. Kidney glycogen content increased significantly (P<0·05) while liver and skeletal muscle glycogen content decreased significantly (P<0·05) in diabetic controls v. normal controls. ZO (500 mg/kg) also significantly decreased kidney glycogen (P<0·05) and increased liver and skeletal muscle glycogen in STZ-diabetic rats when compared to diabetic controls. Activities of glucokinase, phosphofructokinase and pyruvate kinase in diabetic controls were decreased by 94, 53 and 61 %, respectively, when compared to normal controls; and ZO significantly increased (P<0·05) those enzymes' activities in STZ-diabetic rats. Therefore, the present study showed that ginger is a potential phytomedicine for the treatment of diabetes through its effects on the activities of glycolytic enzymes.
AuthorsNafiu Bidemi Abdulrazaq, Maung Maung Cho, Ni Ni Win, Rahela Zaman, Mohammad Tariqur Rahman
JournalThe British journal of nutrition (Br J Nutr) Vol. 108 Issue 7 Pg. 1194-201 (Oct 2012) ISSN: 1475-2662 [Electronic] England
PMID22152092 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoglycemic Agents
  • Plant Extracts
  • Streptozocin
  • Glycogen
Topics
  • Animals
  • Body Weight (drug effects)
  • Carbohydrate Metabolism (drug effects)
  • Diabetes Mellitus, Type 1 (blood, drug therapy, metabolism, pathology)
  • Ginger (chemistry)
  • Gluconeogenesis (drug effects)
  • Glycogen (metabolism)
  • Glycolysis (drug effects)
  • Hyperglycemia (prevention & control)
  • Hypoglycemic Agents (adverse effects, isolation & purification, therapeutic use)
  • Kidney (drug effects, pathology)
  • Lethal Dose 50
  • Liver (drug effects, metabolism, pathology)
  • Male
  • Muscle, Skeletal (drug effects, metabolism)
  • Organ Size (drug effects)
  • Phytotherapy
  • Plant Extracts (adverse effects, isolation & purification, therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Rhizome (chemistry)
  • Streptozocin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: